An integrated analysis of patients with BRAFV600- or NRAS-mutated, and PTEN loss stage IIIB/C melanomas, found that PTEN loss corresponded to a shorter time to brain metastasis and reduced overall survival in BRAFV600-mutated melanomas [93]. Here, PTEN is linked to melanoma.